Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ArriVent Biopharma
ArriVent Biopharma
ArriVent takes in $175M from second biotech IPO of the year
Fierce Biotech
Fri, 01/26/24 - 11:17 am
ArriVent Biopharma
IPOs
furmonertinib
China
non-small cell lung cancer
2024 Brings Surprising Early Surge of Biotech IPOs
BioSpace
Fri, 01/19/24 - 09:43 am
biotech
IPOs
CG Oncology
Alto Neuroscience
ArriVent Biopharma
Kyverna Therapeutics
Metagenomi
Cancer biotech ArriVent Biopharma files for a $100 million IPO
Renaissance Capital
Mon, 01/8/24 - 11:38 am
ArriVent Biopharma
IPOs
cancer
A lean first quarter for venture-backed developers
EP Vantage
Wed, 04/5/23 - 10:02 am
funding
venture capital
ArriVent Biopharma
Flare Therapeutics GSK
Hemab
With one of biotech's largest private rounds in a year, ArriVent enters PhIII
Endpoints
Mon, 03/27/23 - 11:25 am
ArriVent Biopharma
funding
solid tumors